Jakob R Passweg (J Passweg, Jakob Passweg)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 59

Top Venues

Bone marrow transplantation

Blood

Blood advances

Leukemia

Basel University Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Basel University Hospital

Switzerland

Head :: Hematologiy Division

Publications

María Queralt Salas, Diderik-Jan Eikema, Linda Koster, Johan Maertens, Jakob R Passweg, Juergen Finke, Annoek E C Broers, Yener Koc, Nicolaus M Kröger, Zubeyde Nur Ozkurt, María Jesús Pascual-Cascon, Uwe Platzbecker, Gwendolyn Van Gorkom, Thomas Schroeder, José Luis López-Lorenzo, Massimo Martino, Patrizia Chiusolo, Martin Kaufmann, Francesco Onida, Carmelo Gurnari, Christof Scheid, Joanna Drozd-Sokolowska, Kavita Raj, Marie Robin, Donal P McLornan
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (4) (2024)
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, William Boreland, Nicolaus M Kröger, Robert Zeiser, Fabio Ciceri, Thomas Schroeder, Peter Dreger, Jakob R Passweg, Johannes Schetelig, Matthias Stelljes, Igor Wolfgang Blau, Georg-Nikolaus Franke, Katarina Riesner, Hélène M Schoemans, Ivan Moiseev, Zinaida Peric
How risky is a second allogeneic stem cell transplantation? Leukemia (2024)
Romain Guieze, Diderik-Jan Eikema, Linda Koster, Johannes Schetelig, Henrik Sengeloev, Jakob R Passweg, Juergen Finke, Mutlu Arat, Annoek E C Broers, Friedrich Stölzel, Jenny Byrne, Cristina Castilla-Llorente, Peter Dreger, Matthias Eder, Tobias Gedde-Dahl, Nicolaus M Kröger, Josep-María Ribera, Deborah Richardson, Alessandro Rambaldi, Lucrecia Yañez, Michel Van Gelder, Joanna Drozd-Sokołowska, Kavita Raj, Ibrahim Yakoub Agha, Olivier Tournilhac, Donal P McLornan
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, William Boreland, Nicolaus M Kröger, Robert Zeiser, Fabio Ciceri, Thomas Schroeder, Peter Dreger, Jakob R Passweg, Johannes Schetelig, Matthias Stelljes, Igor Wolfgang Blau, Georg-Nikolaus Franke, Katarina Riesner, Hélène M Schoemans, Ivan Moiseev, Zinaida Peric
How risky is a second allogeneic stem cell transplantation? Leukemia 38 (8) (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (7) (2024)
Christof Scheid, Diderik-Jan Eikema, Michel van Gelder, Urpu Salmenniemi, Johan Maertens, Jakob R Passweg, Didier Blaise, Jennifer L Byrne, Nicolaus M Kröger, Katja Sockel, Patrice Chevallier, Jean Henri Bourhis, Jan J Cornelissen, Henrik Sengeløv, Juergen Finke, John A Snowden, Tobias Gedde-Dahl, Jérôme Cornillon, Urs Schanz, Amit Patel, Linda Koster, Liesbeth C de Wreede, Patrick J Hayden, Kavita Raj, Joanna Drozd-Sokołowska, Carmelo Gurnari, Francesco Onida, Donal P McLornan, Marie Robin, Ibrahim Yakoub Agha
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms? Blood 144 (4) (2024)
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Rafael De la Cámara LLanzá, Bertram Glass, Raffaella Greco, Mette D Hazenberg, Krzysztof Kalwak, Donal P McLornan, Bénédicte Neven, Zinaida Perić, Antonio M Risitano, Annalisa Ruggeri, John A Snowden, Anna Sureda
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone marrow transplantation 59 (6) (2024)
David König, Michael T Sandholzer, Sarp Uzun, Andreas Zingg, Reto Ritschard, Helen Thut, Katharina Glatz, Elisabeth Artemis Kappos, Dirk J Schaefer, Christoph Kettelhack, Jakob R Passweg, Andreas Holbro, Katharina Baur, Michael Medinger, Andreas S Buser, Didier Lardinois, Lukas T Jeker, Nina Khanna, Frank Stenner, Benjamin Kasenda, Krisztian Homicsko, Matthias S Matter, Natalia Rodrigues Mantuano, Alfred Zippelius, Heinz Laubli
Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes. Cancer immunology research 12 (7) (2024)
Arnon Nagler, Myriam Labopin, Ryszard Swoboda, Thomas Schroeder, Rose-Marie Hamladji, Laimonas Griskevicius, Urpu Salmenniemi, Alessandro Rambaldi, Stephan Mielke, Alexander Dmitrievich Kulagin, Jakob R Passweg, Thomas Luft, Tobias Gedde-Dahl, Edouard Forcade, Grzegorz Helbig, Matthias Stelljes, Cristina Castilla-Llorente, Alexandros Spirydonidis, Eolia Brissot, Fabio Ciceri, Florent Malard
Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation 59 (7) (2024)
Carmelo Gurnari, Linda Koster, Laurien Baaij, Mael Heiblig, Ibrahim Yakoub Agha, Matthew Collin, Jakob R Passweg, Claude E Bulabois, Anjum Bashir Khan, Michael Loschi, Fabrizio Carnevale-Schianca, Elena Crisà, Daniela Caravelli, Jürgen H E Kuball, Francesco Saraceni, Attilio Olivieri, Alessandro Rambaldi, Austin G Kulasekararaj, Patrick J Hayden, Manuela Badoglio, Francesco Onida, Christof Scheid, Franco Franceschini, Arsenne Mekinian, Sinisa Savic, Maria Teresa Teresa Voso, Joanna Drozd-Sokolowska, John A Snowden, Kavita Raj, Alexander Tobias, Marie Robin, Raffaella Greco, Donal P McLornan
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT. Blood advances 8 (6) (2024)
Christof Scheid, Diderik-Jan Eikema, Michel Van Gelder, Urpu Salmenniemi, Johan Maertens, Jakob R Passweg, Didier Blaise, Jennifer L Byrne, Nicolaus Kroeger, Katja Sockel, Patrice Chevallier, Jean Henri Bourhis, Jan J Cornelissen, Henrik Sengeløv, Juergen Finke, John A Snowden, Tobias Gedde-Dahl, Jérôme Cornillon, Urs Schanz, Amit Patel, Linda Koster, Liesbeth C de Wreede, Patrick J Hayden, Kavita Raj, Joanna Drozd-Sokolowska, Carmelo Gurnari, Francesco Onida, Donal P McLornan, Marie Robin, Ibrahim Yakoub Agha
Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms? Blood (2024)
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, William Boreland, Nicolaus M Kröger, Robert Zeiser, Fabio Ciceri, Thomas Schroeder, Peter Dreger, Jakob R Passweg, Johannes Schetelig, Matthias Stelljes, Igor Wolfgang Blau, Georg-Nikolaus Franke, Katarina Riesner, Hélène M Schoemans, Ivan Moiseev, Zinaida Peric
How risky is a second allogeneic stem cell transplantation? Leukemia 38 (8) (2024)
Christian Niederwieser, Simona Iacobelli, Georg-Nikolaus Franke, Linda Koster, Marleen van Os, Uwe Platzbecker, Kai Hübel, Christof Scheid, Lutz Peter Müller, Matthias Stelljes, Elena Morozova, Jakob R Passweg, Francesco Onida, Peter Dreger, Riccardo Saccardi, Marco Ladetto, Urpu Salmenniemi, Wolfgang Andreas Bethge, Xavier Poiré, Guido Kobbe, Donal P McLornan, Marie Robin, Nicolaus Kröger
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC). Bone marrow transplantation 59 (8) (2024)
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Rafael De la Cámara LLanzá, Bertram Glass, Raffaella Greco, Mette D Hazenberg, Krzysztof Kalwak, Donal P McLornan, Bénédicte Neven, Zinaida Perić, Antonio M Risitano, Annalisa Ruggeri, John A Snowden, Anna Sureda
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone marrow transplantation (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Christian Niederwieser, Simona Iacobelli, Georg-Nikolaus Franke, Linda Koster, Marleen van Os, Uwe Platzbecker, Kai Hübel, Christof Scheid, Lutz Peter Müller, Matthias Stelljes, Elena Morozova, Jakob R Passweg, Francesco Onida, Peter Dreger, Riccardo Saccardi, Marco Ladetto, Urpu Salmenniemi, Wolfgang Andreas Bethge, Xavier Poiré, Guido Kobbe, Donal P McLornan, Marie Robin, Nicolaus Kröger
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC). Bone marrow transplantation 59 (8) (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, William Boreland, Nicolaus M Kröger, Robert Zeiser, Fabio Ciceri, Thomas Schroeder, Peter Dreger, Jakob R Passweg, Johannes Schetelig, Matthias Stelljes, Igor Wolfgang Blau, Georg-Nikolaus Franke, Katarina Riesner, Hélène M Schoemans, Ivan Moiseev, Zinaida Peric
How risky is a second allogeneic stem cell transplantation? Leukemia 38 (8) (2024)
Alicja Sadowska-Klasa, J M Zaucha, Myriam Labopin, J H Bourhis, Didier Blaise, Ibrahim Yakoub Agha, U Salmenniemi, Jakob R Passweg, N Fegueux, T Schroeder, S Giebel, E Brissot, Fabio Ciceri, Florent Malard
Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registry. Bone marrow transplantation 59 (3) (2024)
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Rafael De la Cámara LLanzá, Bertram Glass, Raffaella Greco, Mette D Hazenberg, Krzysztof Kalwak, Donal P McLornan, Bénédicte Neven, Zinaida Perić, Antonio M Risitano, Annalisa Ruggeri, John A Snowden, Anna Sureda
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone marrow transplantation 59 (6) (2024)
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Rafael De la Cámara LLanzá, Bertram Glass, Raffaella Greco, Mette D Hazenberg, Krzysztof Kalwak, Donal P McLornan, Bénédicte Neven, Zinaida Perić, Antonio M Risitano, Annalisa Ruggeri, John A Snowden, Anna Sureda
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone marrow transplantation 59 (6) (2024)
Juan Montoro Gómez, Diderik-Jan Eikema, Joe Tuffnell, Victoria Potter, Krzyzstof Kalwak, Constantijn Jm Jm Halkes, Alexander Dmitrievich Kulagin, Matthew Collin, Robert F Wynn, Stephen Robinson, Emma Nicholson, Henrik Sengeløv, Khalid Halahleh, Elena Skorobogatova, Jaime Sanz Caballer, Jakob R Passweg, Stephan Mielke, Samppa Johannes Ryhänen, Ben Carpenter, Tobias Gedde-Dahl, Eleni Tholouli, Renato Fanin, Philippe Lewalle, Austin G Kulasekararaj, Antonio Maria Risitano, Régis Peffault de Latour
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT. Blood (2024)
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Rafael De la Cámara LLanzá, Bertram Glass, Raffaella Greco, Mette D Hazenberg, Krzysztof Kalwak, Donal P McLornan, Bénédicte Neven, Zinaida Perić, Antonio M Risitano, Annalisa Ruggeri, John A Snowden, Anna Sureda
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone marrow transplantation 59 (6) (2024)
Alicja Sadowska-Klasa, J M Zaucha, Myriam Labopin, J H Bourhis, Didier Blaise, Ibrahim Yakoub Agha, U Salmenniemi, Jakob R Passweg, N Fegueux, T Schroeder, S Giebel, E Brissot, Fabio Ciceri, Florent Malard
Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registry. Bone marrow transplantation (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (7) (2024)
Christof Scheid, Diderik-Jan Eikema, Michel van Gelder, Urpu Salmenniemi, Johan Maertens, Jakob R Passweg, Didier Blaise, Jennifer L Byrne, Nicolaus M Kröger, Katja Sockel, Patrice Chevallier, Jean Henri Bourhis, Jan J Cornelissen, Henrik Sengeløv, Juergen Finke, John A Snowden, Tobias Gedde-Dahl, Jérôme Cornillon, Urs Schanz, Amit Patel, Linda Koster, Liesbeth C de Wreede, Patrick J Hayden, Kavita Raj, Joanna Drozd-Sokołowska, Carmelo Gurnari, Francesco Onida, Donal P McLornan, Marie Robin, Ibrahim Yakoub Agha
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms? Blood 144 (4) (2024)
Alicja Sadowska-Klasa, J M Zaucha, Myriam Labopin, J H Bourhis, Didier Blaise, Ibrahim Yakoub Agha, U Salmenniemi, Jakob R Passweg, N Fegueux, T Schroeder, S Giebel, E Brissot, Fabio Ciceri, Florent Malard
Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registry. Bone marrow transplantation 59 (3) (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (7) (2024)
Christian Niederwieser, Simona Iacobelli, Georg-Nikolaus Franke, Linda Koster, Marleen van Os, Uwe Platzbecker, Kai Hübel, Christof Scheid, Lutz Peter Müller, Matthias Stelljes, Elena Morozova, Jakob R Passweg, Francesco Onida, Peter Dreger, Riccardo Saccardi, Marco Ladetto, Urpu Salmenniemi, Wolfgang Andreas Bethge, Xavier Poiré, Guido Kobbe, Donal P McLornan, Marie Robin, Nicolaus Kröger
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC). Bone marrow transplantation (2024)
Marie Janscak, Anne Stelmes, Jana van den Berg, Dominik Heim, Joerg P Halter, Beatrice Drexler, Christian Arranto, Jakob R Passweg, Michael Medinger
Influence of comorbidities on outcome in 1102 patients with an allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation (2024)
Carmelo Gurnari, Linda Koster, Laurien Baaij, Mael Heiblig, Ibrahim Yakoub Agha, Matthew Collin, Jakob R Passweg, Claude E Bulabois, Anjum Bashir Khan, Michael Loschi, Fabrizio Carnevale-Schianca, Elena Crisà, Daniela Caravelli, Jürgen H E Kuball, Francesco Saraceni, Attilio Olivieri, Alessandro Rambaldi, Austin G Kulasekararaj, Patrick J Hayden, Manuela Badoglio, Francesco Onida, Christof Scheid, Franco Franceschini, Arsenne Mekinian, Sinisa Savic, Maria Teresa Teresa Voso, Joanna Drozd-Sokolowska, John A Snowden, Kavita Raj, Alexander Tobias, Marie Robin, Raffaella Greco, Donal P McLornan
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT. Blood advances 8 (6) (2024)
Carmelo Gurnari, Linda Koster, Laurien Greetje Antoinette Baaij, Mael Heiblig, Ibrahim Yakoub Agha, Matthew Collin, Jakob R Passweg, Claude-Eric Bulabois, Anjum Bashir Khan, Michael Loschi, Fabrizio Carnevale-Schianca, Elena Crisà, Daniela Caravelli, Jürgen H E Kuball, Francesco Saraceni, Attilio Olivieri, Alessandro Rambaldi, Austin G Kulasekararaj, Patrick Hayden, Manuela Badoglio, Francesco Onida, Christof Scheid, Franco Franceschini, Arsenne Mekinian, Sinisa Savic, Maria Teresa Teresa Voso, Joanna Drozd-Sokolowska, John A Snowden, Kavita Raj, Alexander Tobias, Marie Robin, Raffaella Greco, Donal P McLornan
Allogeneic Hematopoietic Cell Transplantation for VEXAS Syndrome: Results of a Multicenter Study of the EBMT. Blood advances (2024)
María Queralt Salas, Diderik-Jan Eikema, Linda Koster, Johan Maertens, Jakob R Passweg, Juergen Finke, Annoek E C Broers, Yener Koc, Nicolaus M Kröger, Zubeyde Nur Ozkurt, María Jesús Pascual-Cascon, Uwe Platzbecker, Gwendolyn Van Gorkom, Thomas Schroeder, José Luis López-Lorenzo, Massimo Martino, Patrizia Chiusolo, Martin Kaufmann, Francesco Onida, Carmelo Gurnari, Christof Scheid, Joanna Drozd-Sokolowska, Kavita Raj, Marie Robin, Donal P McLornan
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Rafael De la Cámara LLanzá, Bertram Glass, Raffaella Greco, Mette D Hazenberg, Krzysztof Kalwak, Donal P McLornan, Bénédicte Neven, Zinaida Perić, Antonio M Risitano, Annalisa Ruggeri, John A Snowden, Anna Sureda
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone marrow transplantation (2024)
María Queralt Salas, Diderik-Jan Eikema, Linda Koster, Johan Maertens, Jakob R Passweg, Juergen Finke, Annoek E C Broers, Yener Koc, Nicolaus M Kröger, Zubeyde Nur Ozkurt, María Jesús Pascual-Cascon, Uwe Platzbecker, Gwendolyn Van Gorkom, Thomas Schroeder, José Luis López-Lorenzo, Massimo Martino, Patrizia Chiusolo, Martin Kaufmann, Francesco Onida, Carmelo Gurnari, Christof Scheid, Joanna Drozd-Sokolowska, Kavita Raj, Marie Robin, Donal P McLornan
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (4) (2024)
Juan Montoro Gómez, Dirk-Jan Eikema, Joe Tuffnell, Victoria Potter, Krzyzstof Kalwak, Constantijn Jm Jm Halkes, Alexander Dmitrievich Kulagin, Matthew Collin, Robert F Wynn, Stephen Robinson, Emma Nicholson, Henrik Sengeløv, Jennifer Clay, Khalid Halahleh, Elena Skorobogatova, Jaime Sanz Caballer, Jakob R Passweg, Stephan Mielke, Samppa Johannes Ryhänen, Ben Carpenter, Tobias Gedde-Dahl, Eleni Tholouli, Renato Fanin, Philippe Lewalle, Austin G Kulasekararaj, Antonio Maria Risitano, Régis Peffault de Latour
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT. Blood 144 (3) (2024)
Christian Niederwieser, Simona Iacobelli, Georg-Nikolaus Franke, Linda Koster, Marleen van Os, Uwe Platzbecker, Kai Hübel, Christof Scheid, Lutz Peter Müller, Matthias Stelljes, Elena Morozova, Jakob R Passweg, Francesco Onida, Peter Dreger, Riccardo Saccardi, Marco Ladetto, Urpu Salmenniemi, Wolfgang Andreas Bethge, Xavier Poiré, Guido Kobbe, Donal P McLornan, Marie Robin, Nicolaus Kröger
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC). Bone marrow transplantation 59 (8) (2024)
David König, Michael T Sandholzer, Sarp Uzun, Andreas Zingg, Reto Ritschard, Helen Thut, Katharina Glatz, Elisabeth Artemis Kappos, Dirk J Schaefer, Christoph Kettelhack, Jakob R Passweg, Andreas Holbro, Katharina Baur, Michael Medinger, Andreas S Buser, Didier Lardinois, Lukas T Jeker, Nina Khanna, Frank Stenner, Benjamin Kasenda, Krisztian Homicsko, Matthias S Matter, Natalia Rodrigues Mantuano, Alfred Zippelius, Heinz Laubli
Melanoma clonal heterogeneity leads to secondary resistance after adoptive cell therapy with tumor-infiltrating lymphocytes. Cancer immunology research (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Rafael De la Cámara LLanzá, Bertram Glass, Raffaella Greco, Mette D Hazenberg, Krzysztof Kalwak, Donal P McLornan, Bénédicte Neven, Zinaida Perić, Antonio M Risitano, Annalisa Ruggeri, John A Snowden, Anna Sureda
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone marrow transplantation 59 (6) (2024)
Enrico Maffini, Myriam Labopin, Nicolaus Kröger, Juergen Finke, Matthias Stelljes, Thomas Schroeder, Hermann Einsele, Johanna Tischer, Martin Bornhäuser, Wolfgang Andreas Bethge, Arne Brecht, Wolf Rösler, Peter Dreger, Kerstin Schäfer-Eckart, Jakob R Passweg, Igor Wolfgang Blau, Arnon Nagler, Fabio Ciceri, Florent Malard
Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone marrow transplantation 59 (7) (2024)
Romain Guieze, Diderik-Jan Eikema, Linda Koster, Johannes Schetelig, Henrik Sengeloev, Jakob R Passweg, Juergen Finke, Mutlu Arat, Annoek E C Broers, Friedrich Stölzel, Jenny Byrne, Cristina Castilla-Llorente, Peter Dreger, Matthias Eder, Tobias Gedde-Dahl, Nicolaus M Kröger, Josep-María Ribera, Deborah Richardson, Alessandro Rambaldi, Lucrecia Yañez, Michel Van Gelder, Joanna Drozd-Sokołowska, Kavita Raj, Ibrahim Yakoub Agha, Olivier Tournilhac, Donal P McLornan
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (7) (2024)
Arnon Nagler, Myriam Labopin, Ryszard Swoboda, Thomas Schroeder, Rose-Marie Hamladji, Laimonas Griskevicius, Urpu Salmenniemi, Alessandro Rambaldi, Stephan Mielke, Alexander Dmitrievich Kulagin, Jakob R Passweg, Thomas Luft, Tobias Gedde-Dahl, Edouard Forcade, Grzegorz Helbig, Matthias Stelljes, Cristina Castilla-Llorente, Alexandros Spirydonidis, Eolia Brissot, Fabio Ciceri, Florent Malard
Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation (2024)
Carmelo Gurnari, Linda Koster, Laurien Baaij, Mael Heiblig, Ibrahim Yakoub Agha, Matthew Collin, Jakob R Passweg, Claude E Bulabois, Anjum Bashir Khan, Michael Loschi, Fabrizio Carnevale-Schianca, Elena Crisà, Daniela Caravelli, Jürgen H E Kuball, Francesco Saraceni, Attilio Olivieri, Alessandro Rambaldi, Austin G Kulasekararaj, Patrick J Hayden, Manuela Badoglio, Francesco Onida, Christof Scheid, Franco Franceschini, Arsenne Mekinian, Sinisa Savic, Maria Teresa Teresa Voso, Joanna Drozd-Sokolowska, John A Snowden, Kavita Raj, Alexander Tobias, Marie Robin, Raffaella Greco, Donal P McLornan
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT. Blood advances 8 (6) (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
María Queralt Salas, Diderik-Jan Eikema, Linda Koster, Johan Maertens, Jakob R Passweg, Juergen Finke, Annoek E C Broers, Yener Koc, Nicolaus M Kröger, Zubeyde Nur Ozkurt, María Jesús Pascual-Cascon, Uwe Platzbecker, Gwendolyn Van Gorkom, Thomas Schroeder, José Luis López-Lorenzo, Massimo Martino, Patrizia Chiusolo, Martin Kaufmann, Francesco Onida, Carmelo Gurnari, Christof Scheid, Joanna Drozd-Sokolowska, Kavita Raj, Marie Robin, Donal P McLornan
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (4) (2024)
Rama Al Hamed, Myriam Labopin, De-Pei Wu, Tobias Gedde-Dahl, Mahmoud Aljurf, Edouard Forcade, Urpu Salmenniemi, Jakob R Passweg, Johan Maertens, Thomas Pabst, Jurjen Versluis, Maija Itäla-Remes, Xiao-Jun Huang, Gwendolyn Van Gorkom, Thomas Schroeder, Jaime Sanz Caballer, Didier Blaise, Péter Reményi, Urs Schanz, Aleksandra Holowiecka, Norbert-Claude Gorin, Fabio Ciceri, Florent Malard
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT. Bone marrow transplantation (2024)
Marie Robin, Simona Iacobelli, Linda Koster, Jakob R Passweg, Daniele Avenoso, Keith M O Wilson, Urpu Salmenniemi, Peter Dreger, Peter A von dem Borne, John A Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, José Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokołowska, Kavita Raj, Juan Carlos Carlos Hernández-Boluda, Donal P McLornan
Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Enrico Maffini, Myriam Labopin, Nicolaus Kröger, Juergen Finke, Matthias Stelljes, Thomas Schroeder, Hermann Einsele, Johanna Tischer, Martin Bornhäuser, Wolfgang Andreas Bethge, Arne Brecht, Wolf Rösler, Peter Dreger, Kerstin Schäfer-Eckart, Jakob R Passweg, Igor Wolfgang Blau, Arnon Nagler, Fabio Ciceri, Florent Malard
Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone marrow transplantation (2024)
Lok Lam Ngai, Diana Hanekamp, Fleur Janssen, Jannemieke Carbaat-Ham, Maaike A M Hofland, Mona M H E Fayed, Angèle Kelder, Laura Oudshoorn-van Marsbergen, Willemijn J Scholten, Alexander N Snel, Costa Bachas, Jesse Marc Tettero, Dimitri A Breems, Thomas Fischer, Bjorn Tore Gjertsen, Laimonas Griskevicius, Gunnar Juliusson, Arjan A van de Loosdrecht, Johan A Maertens, Markus Gabriel Manz, Thomas Pabst, Jakob R Passweg, Kimmo Porkka, Peter J M Valk, Patrycja L Gradowska, Bob Löwenberg, David C de Leeuw, Jeroen J W M Janssen, Gert J Ossenkoppele, Jacqueline Cloos
Prospective Validation of the Prognostic Relevance of CD34+CD38- AML Stem Cell frequency in the HOVON-SAKK132 trial. Blood (2023)
Tamara Codilupi, Jakub Szybinski, Stefanie Arunasalam, Sarah Jungius, Andrew J Dunbar, Simona Stivala, Sime Brkic, Camille Albrecht, Lenka Vokalova, Julie L Yang, Katarzyna Buczak, Nilabh Ghosh, Jakob R Passweg, Alicia Rovo, Anne Angelillo-Scherrer, Dmitry Pankov, Stephan Dirnhofer, Ross L Levine, Richard P Koche, Sara C Meyer
Development of resistance to type II JAK2 inhibitors in MPN depends on AXL kinase and is targetable. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Silvio Ragozzino, Nicolas J Mueller, Dionysios Neofytos, Jakob R Passweg, Antonia Müller, Michael Medinger, Christian Van Delden, Stavroula Masouridi-Levrat, Yves Chalandon, Sarah Tschudin-Sutter, Nina Khanna, null null
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study. Bone marrow transplantation (2023)
Alexandros Spirydonidis, Myriam Labopin, Tobias Gedde-Dahl, Arnold Ganser, Matthias Stelljes, Charles F Craddock, Eva Maria Wagner-Drouet, Jurjen Versluis, Thomas Schroeder, Igor Wolfgang Blau, Gerald G Wulf, Peter Dreger, Gitte Olesen, Henrik Sengeloev, Nicolaus M Kröger, Victoria Potter, Edouard Forcade, Jakob R Passweg, Régis Peffault de Latour, Johan A Maertens, Keith M O Wilson, Jean Henri Bourhis, Juergen Finke, Eolia Brissot, Ali Bazarbachi, Sebastian Giebel, Bipin P Savani, Arnon Nagler, Fabio Ciceri, Florent Malard
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation. Bone marrow transplantation (2023)
Astrid Beerlage, Karoline Leuzinger, Luca Valore, Roby Mathew, Till Junker, Beatrice Drexler, Jakob R Passweg, Hans H Hirsch, Joerg P Halter
Antibody response to mRNA SARS-CoV-2 vaccination in 182 patients after allogeneic hematopoietic cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society 24 (3) (2022)
Franziska C Adam, Jakub Szybinski, Joerg P Halter, Nathan Cantoni, Friedel Wenzel, Katharina Leonards, Sime Brkic, Jakob R Passweg, Ivo Touw, Julia E Maxson, Sara C Meyer
Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia. Current oncology (Toronto, Ont.) 29 (2) (2022)
Silas Bänziger, Kimmo Weisshaar, Reetta Arokoski, Sabine Gerull, Joerg P Halter, Alicia Rovo, Mario Bargetzi, Jeroen S Goede, Yuliya Senft, Sabine Valenta, Jakob R Passweg, Beatrice Drexler
Feasibility of electronic patient-reported outcome monitoring and self-management program in aplastic anemia and paroxysmal nocturnal hemoglobinuria-a pilot study (ePRO-AA-PNH). Annals of hematology (2022)
Stéphane Buhler, Helen Baldomero, Sylvie Ferrari-Lacraz, Anne-Claire Mamez, Stavroula Masouridi-Levrat, Dominik Heim, Joerg P Halter, Gayathri Nair, Yves Chalandon, Urs Schanz, Tayfun Güngör, Grazia Nicoloso, Jakob R Passweg, Jean Villard, null null
Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation. Blood advances 5 (17) (2021)
Giorgia Battipaglia, Myriam Labopin, Nicolaus Kröger, Antonin Vitek, Boris Afanasyev, Inken Hilgendorf, Johannes Schetelig, Arnold Ganser, Didier Blaise, Maija Itälä-Remes, Jakob R Passweg, Francesca Bonifazi, Jurgen Finke, Annalisa Ruggeri, Arnon Nagler, Mohamad Mohty
Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation. Blood 134 (11) (2019)

Jakob R Passweg.css-eqlu8i{font-size:small;padding-left:4px;} (J Passweg, Jakob Passweg)

Publication Activity (10 Years)

Top Topics

Top Venues

Jakob R Passweg (J Passweg, Jakob Passweg)